AZD1480 can inhibit the biological behavior of ovarian cancer SKOV3 cells in vitro

Asian Pac J Cancer Prev. 2013;14(8):4823-7. doi: 10.7314/apjcp.2013.14.8.4823.

Abstract

Objective: To study the mechanism of effects of AZD1480 on the SKOV3 ovarian cancer cell line.

Methods: The MTT method was used to assess cellular proliferation, flow cytometry for cellular apoptosis, the scratch test to determine migration, transwell chamber assays to detect cellular invasion, plate clone experiments to detect the clone forming ability and Western blotting to determine p-STAT3 protein levels.

Results: The proliferation rate, migration ability, invasiveness and the clone forming ability of SKOV3 cells were reduced after treatment with AZD1480, while apoptosis rate and chemotherapeutic susceptibility were increased. After treatment with AZD1480 plus cisplatin, the apoptosis rate increased significantly while the expression level of p-STAT3 protein was decreased.

Conclusion: AZD1480 can inhibit the proliferation, invasion, metastasis and clone formation of SKOV3 cells, induce cellulsar apoptosis, increase the chemotherapeutic sensitivity and reduce the expression level of p-STAT3 protein.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols
  • Apoptosis / drug effects*
  • Blotting, Western
  • Cell Movement / drug effects*
  • Cell Proliferation / drug effects*
  • Cisplatin / pharmacology
  • Female
  • Flow Cytometry
  • Humans
  • In Vitro Techniques
  • Janus Kinase 2 / antagonists & inhibitors
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology*
  • Pyrazoles / pharmacology*
  • Pyrimidines / pharmacology*
  • Tumor Cells, Cultured

Substances

  • AZD 1480
  • Antineoplastic Agents
  • Pyrazoles
  • Pyrimidines
  • Janus Kinase 2
  • Cisplatin